MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Coenzyme Q0

CAS No. : 605-94-7

MCE 站：Coenzyme Q0

产品活性：Coenzyme Q0 (CoQ0) 是一种口服有效的醌类化合物，可以从 Antrodia cinnamomea 中得到。Coenzyme Q0 诱导细胞凋亡 (apoptosis) 和自噬 (autophagy)，抑制 HER-2/AKT/mTOR 信号通路来增强细胞凋亡和自噬机制。Coenzyme Q0 调节 NFκB/AP-1 的激活，并增强 Nrf2 的稳定，减轻炎症和氧化还原失衡。Coenzyme Q0 通过下调 MMP-9/NF-κB 和上调 HO-1 信号通路具有抗血管生成活性。

研究领域：Apoptosis  |  Autophagy  |  JAK/STAT Signaling  |  Protein Tyrosine Kinase/RTK  |  PI3K/Akt/mTOR  |  Immunology/Inflammation  |  NF-κB  |  Metabolic Enzyme/Protease  |  Cell Cycle/DNA Damage  |  Epigenetics

作用靶点：Apoptosis  |  Autophagy  |  EGFR  |  Akt  |  mTOR  |  Caspase  |  Bcl-2 Family  |  Reactive Oxygen Species  |  PARP  |  COX  |  NO Synthase  |  TNF Receptor  |  Interleukin Related  |  MMP  |  NF-κB

In Vitro: Coenzyme Q0 (0-40 M; 24 h) ａnd inhibits viability ａnd growth of human ovarian carcinoma cells.
Coenzyme Q0 (CoQ0) (0-30 M; 24 h; SKOV-3 cells) has anti-proliferative activity through induction of G2/M cell-cycle arrest ａnd reduction of cell-cycle regulatory proteins.
Coenzyme Q0 (CoQ0) (0-30 M; 0-30 min; SKOV-3 cells) increases intracellular ROS levels to promote SKOV-3 cell death.
Coenzyme Q0 (CoQ0) (0-30 M; 24 h; SKOV-3 cells) induces autophagy by increase accumulation of LC3-II, GFP-LC3 puncta, AVOs formation ａnd Beclin-1/Bcl-2 dysregulation.
Coenzyme Q0 (CoQ0) (0-30 M; 24 h; SKOV-3 cells) induces apoptosis by mitochondrial (caspase-3, PARP ａnd Bax/Bcl-2 dysregulation) ａnd ER stress (caspase-12 ａnd Hsp70) signals.
Coenzyme Q0 (CoQ0) (30 M; 24 h; SKOV-3 cells) suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis ａnd autophagy mechanisms.
Coenzyme Q0 (CoQ0) (0-10 M; 0.5-18 h; RAW264.7 cells) regulates NFκB/AP-1 activation ａnd enhances Nrf2 stabilization.
Coenzyme Q0 (CoQ0) (5 M; 0-12 h; EA.hy 926 cells) has anti-angiogenic activity in EA.hy 926 cells.

In Vivo: Coenzyme Q0 (CoQ0) (1.5 ａnd 2.5 mg/kg; i.p.; once every four days, for 52 d) suppresses tumor growth in SKOV-3 xenografted nude mice.
Coenzyme Q0(CoQ0) (5 mg/kg; p.o.; for 4 h) has anti-inflammatory activities through Nrf2 activation ａnd NFκB inhibition in liver ａnd spleen of LPS-treated mice.

相关产品：MG-132  |  Rapamycin  |  LY294002  |  Phorbol 12-myristate 13-acetate  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Olaparib  |  Y-27632 dihydrochloride  |  Paclitaxel  |  Z-VAD-FMK  |  Venetoclax  |  Acetylcysteine  |  Tamoxifen  |  Deferoxamine mesylate  |  Angiotensin II human  |  Staurosporine  |  Bortezomib  |  2-Deoxy-D-glucose  |  5-Fluorouracil  |  H2DCFDA  |  Sorafenib  |  SP600125  |  Trametinib  |  Resatorvid  |  Temozolomide  |  Gemcitabine  |  Navitoclax  |  Osimertinib  |  MK-2206 dihydrochloride

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物  |  寡核苷酸

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。